Navigation Links
ADVENTRX to Present CoFactor Multiagent Therapy Data at AACR Annual,,,Meeting

drug metabolism, bioavailability, excessive toxicity and treatment resistance. More information can be found on the Company's web site at http://www.adventrx.com.

Forward Looking Statement

ADVENTRX cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors that, if they do not materialize or prove to be accurate, could cause ADVENTRX's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties that could cause actual results for our CoFactor studies to differ materially include, but are not limited to: the validity of research results; uncertainties inherent in the drug development process; the timing and success of clinical trials; the receipt of necessary approvals from the FDA and other regulatory agencies; and other risks and uncertainties more fully described in ADVENTRX's press releases and public filings with the Securities and Exchange Commission. ADVENTRX's public filings with the Securities and Exchange Commission are available at www.sec.gov. ADVENTRX does not intend to update any forward-looking statement, including as set forth in this press release, to reflect events or circumstances arising after the date on which it was made.

CONTACT: Investors, Ioana C. Hone of ADVENTRX Pharmaceuticals,+1-858-552-0866; or Amy Martini of WeissComm Partners, +1-212-301-7223, forADVENTRX Pharmaceuticals, Inc.

Web site: http://www.adventrx.com/

Company News On-Call: http://www.prnewswire.com/gh/cnoc
'"/>




Page: 1 2 3

Related medicine technology :

1. ADVENTRX Announces Positive Data From Preclinical Pharmacokinetic Testing of ANX-514 (Docetaxel Emulsion)
2. The Past, Present and Future of HLA Typing
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
11. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference

Post Your Comments:
(Date:11/25/2009)...ccordingtoMillenniumResearchGroup(MRG),theglobalau...arly$3billionUSmarketfortraumafixationdeviceswillc...therecenteconomicslowdown.MRG,s USMarketsforTrauma...ighlydynamicoverthenextfiveyears,withcompetitorsin...segmentsofthetraumafixationmarket,fuelingmarketgro...
(Date:11/25/2009)...-CempraPharmaceuticalsInc.todayannouncedthatPrabha...illpresentatthePiperJaffray21stAnnualHealthCareCon...laceHotelinNewYorkCity.Dr.Fernandeswillprovideanov...ogramsforthetreatmentofdrug-resistantpathogensincl..., Foundedin2006,CempraPharmaceuticalsisaprivately-...
(Date:11/25/2009)...inker.comannouncesthatanewmarketresearchreportisav...ry-USMarketTrends&Analysis http://www.reportl...arket-Trends--Analysis.html ,, TheUSintranasal...uticapplicationsfromthedeliveryofconventionallocal...drugs.Thefutureofthetechnologyhingesontotheeffecti...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Allsup Outlines Role of Social Security Disability Insurance for Obtaining Medicare Benefits 56509 1Allsup Outlines Role of Social Security Disability Insurance for Obtaining Medicare Benefits 56509 2Allsup Outlines Role of Social Security Disability Insurance for Obtaining Medicare Benefits 56509 3Allsup Outlines Role of Social Security Disability Insurance for Obtaining Medicare Benefits 56509 4First Results From Major European Patient Survey Show Devastating Impact of Living With Breakthrough Cancer Pain 56504 1First Results From Major European Patient Survey Show Devastating Impact of Living With Breakthrough Cancer Pain 56504 2First Results From Major European Patient Survey Show Devastating Impact of Living With Breakthrough Cancer Pain 56504 3Work conditions impact parents food choices 9834 1Work conditions impact parents food choices 9834 2
... presented at American College of Rheumatology Ann...uibb Company,(NYSE: BMY ) today announced the res... pivotal trials that showed ORENCIA(R) (abatacept)...rk or household chores, physical and,social-role i...arthritis,(RA) patients who have had an inadequate...
... ANTIPOLIS, France, Nov. 12 NicOx S.A.,(Eurolist:...pivotal phase 3,trial for naproxcinod in patients ...re presented on November 10, 2007 at the 71st annu... (ACR), in Boston, Massachusetts (see,NOTE). Napro... and the,first compound in the COX-Inhibiting Nitr...
Other Medicine Technology:Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept) 2Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept) 3Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept) 4Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept) 5Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept) 6Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept) 7Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept) 8Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept) 9NicOx' Naproxcinod Phase 3 Results Presented at American College of Rheumatology 2NicOx' Naproxcinod Phase 3 Results Presented at American College of Rheumatology 3NicOx' Naproxcinod Phase 3 Results Presented at American College of Rheumatology 4
(Date:11/27/2009)... Voyant Health™ announced today tha...ensed its TraumaCad Enterprise orthopedic templati...tion. , (PRWEB) November ...hat Spectrum Health (Grand Rapids, Michigan) has l...ting solution and its TraumaCad Extend workflow so...
(Date:11/27/2009)... Specialist manufacturers who use medical...ing millions of dollars by bringing in technology ...asing numbers of pro-active medical manufacturers ...ncept stage of their projects, ensuring that progr...cesses or potentially outdated technology. , ...
(Date:11/26/2009)...Nov.27/PRNewswire/--Withcoldandfluseasonuponus,it,...olthespreadofinfectionsandavoidillness. ,, "Wen...oavoidtransmittingillnessifwe,resick,"saidEileenFi...ingdirectorforinfectioncontrolandoccupationalhealt..., HospitalforSpecialSurgeryhasoneofthelowestinfect...
(Date:11/26/2009)... years, the number of Americans living with diabet...n in 2009 to 44.1 million in 2034. Over the same p...sing from $113 billion to $336 billion, even with ...ers based at the University of Chicago report in t...er of those with diabetes covered by Medicare will...
(Date:11/26/2009)...oo big or too heavy can lead to strains or worse ,... There may be nothing wrong with stuffing your tur... the same thing with your suitcase as you pack for...treated in 2008 in U.S. hospital emergency rooms, ...ties for luggage-related injuries, such as muscle ...
Breaking Medicine News(10 mins):Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Pack Right for the Holidays to Avoid the ER 2
...ccording to a recent study in the U.S, divorce aff... Fred Lorenz, who co-authored the report at Iowa S...ural Research, said: “What we found was that the a...s on mental health led to effects in physical heal...
... recent study reveals that 1-in-8 children with ty... The allergy to gluten, largely present in w...rized by intestinal cramping, pain, bloating, diar...ng-term effects on growth were restored. D...
... hospital in London has developed a flat computer ...es of methicillin-resistant staphylococcus // aure...fections that kill 5,000 people each year in Brita...ance to most penicillins. Research shows tha...
...ospital wards in some of Russia's most remote loca...ores of patients, almost exclusively men, have bee...ng as a result of drinking bootleg vodka. Hund...ost of the numerous victims taken to hospitals ove...
...easure your waist regularly, because the size of y...racting cardiovascular diseases, // according to n...n origin. According to Kamlesh Khunti, senior c...rently over half of women and two-thirds of men in...
...hile the government officials continue to extol th...ve taken to the streets to protest against the pol...ecounts tales of falling waiting lists and increas...isastrous policies. Pensioners and health staf...
Other Medicine News:Health News:New Flat Keyboard To Tackle Hospital Super Bug 2Health News:Russia Hit By Cheap Bootleg Vodka Epidemic 2Health News:Wide Differences between NHS staff and ministers 2
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
Medicine Products: